
|Articles|July 20, 2012
How Fake Cancer Drugs Entered U.S.
Advertisement
Pfizer
PFE
-0.40%
GlaxoSmithKline
GSK
-0.92%
From the outskirts of Winnipeg, Kris Thorkelson's Canada Drugs grew to become a vital link for American consumers stung by high drug prices. The Internet pharmacy had by the middle part of the last decade filled millions of U.S. prescriptions with low-cost, Canadian supplies of everything from Inc.'s cholesterol pill Lipitor to PLC's asthma treatment Advair.
Read the full story:
Source: The Wall Street Journal
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
5 Things to Know About the Oral GLP-1 Era
4
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
5









